ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Repros Therapeutics Inc. 

2408 Timberloch Place
Suite B-7
The Woodlands  Texas  77380  U.S.A.
Phone: 281-719-3400 Fax: 281-719-3446


SEARCH JOBS








 Company News
Repros Therapeutics Inc. (RPRX) Fully Enrolls First Of Two Previously Announced Head To Head Studies Of Androxal® Versus The Leading Topical Testosterone Gel 4/14/2014 9:14:57 AM    More...
Repros Therapeutics Inc. (RPRX) Allowed To Conduct Phase 1 And 2 Clinical Studies Of Low Dose Oral Proellex® In The Treatment Of Uterine Fibroids And Endometriosis 3/18/2014 8:57:38 AM    More...
Repros Therapeutics Inc. (RPRX) Allowed To Conduct Phase 1 And 2 Clinical Studies Of Low Dose Oral Proellex® In The Treatment Of Uterine Fibroids And Endometriosis 3/17/2014 9:10:37 AM    More...
Repros Therapeutics Inc. (RPRX) Reports Fourth Quarter And Year End 2013 Financial Results 3/13/2014 8:51:02 AM    More...
Repros Therapeutics Inc. (RPRX) Reports Findings From The Six Month Study Of Androxal® In Men With Secondary Hypogonadism 2/10/2014 9:24:02 AM    More...
Repros Therapeutics Inc. (RPRX) Meets With FDA To Discuss Data Requirements For Androxal® In The Treatment Of Secondary Hypogonadism 2/6/2014 9:41:43 AM    More...
Repros Therapeutics Inc. (RPRX) Initiates Two Head To Head Studies Of Androxal® Versus The Leading Topical Testosterone Gel 1/8/2014 9:08:16 AM    More...
Repros Therapeutics Inc. (RPRX) Adds Marketing And Commercialization Expertise To Board Of Directors 12/20/2013 9:55:32 AM    More...
Repros Therapeutics Inc. (RPRX) To Present Data On The Benefits Of Testosterone Restoration With Androxal® Compared To T Replacement With Gels At 9th Men's Health World Congress 11/26/2013 9:57:58 AM    More...
FDA Schedules Face To Face Meeting With Repros Therapeutics Inc. (RPRX) To Discuss Androxal® Efficacy 11/25/2013 9:29:43 AM    More...
12345678910...